Blogs

We have asked you to tweet us , follow us , pin us , and read with us ! Well I am excited to announce that we would love for you to ’gram us as well! JDRF Advocacy is excited to announce our newest social media neighborhood, Instagram ! The Instagram...

In 1983, a trial began that would forever alter the standard of management of type 1 diabetes (T1D) and serve as a stepping stone to future research advances—and as we mark the 30th anniversary of the trial’s inception, we are still learning...

JDRF recently brought together a group of 20 leading experts in the behavioral and mental health fields to discuss the range of psychological and social issues experienced by people with type 1 diabetes (T1D) and their families. Forums like this enable...

Advocates, here we are, February 14, Valentine’s Day! Happy Valentine’s Day to you and to your #1! Here on the JDRF Grassroots team, we wanted to make sure you felt the love we exude for you today. We wanted to make sure you knew just how...

In order to prevent and ultimately achieve a world without type 1 diabetes (T1D), we must first learn more about the disease. One trend that has revealed itself in recent years is an accelerating rate of T1D, especially among younger children. Last year...

When JDRF started the Artificial Pancreas Project in 2006, the project was long on theoretical concepts but short on hard data. Scientists believed there should be a way to improve daily T1D management by connecting the reading from a continuous glucose...

JDRF was founded 42 years ago, by parents of children with type 1 diabetes (T1D) in 1970. For the past 42 years, JDRF staff and volunteers have worked together to fund research aimed at finding a cure, better treating and preventing T1D. This year, the...

Living with type 1 diabetes (T1D), to say the least, is no cake walk. Let’s be honest, it’s downright tiring and absolutely challenging sometimes. Despite this truth, and in the face of nearly impossible obstacles, people with T1D still do...

Congrats again, JDRFers! As one of the final acts of the 112th Congress, the U.S. House of Representatives and U.S. Senate approved a broad bipartisan bill that included $150 million for the Special Diabetes Program (SDP), extending the program for an...

Thanks to you and your advocacy efforts on behalf of JDRF! I am happy to report that early this morning (around 2:15 am to be more exact!), the U.S. Senate passed legislation which includes a one-year renewal of the Special Diabetes Program (SDP) at the...

In September, JDRF wrapped up the first stage of its first-ever crowdsourcing challenge to garner ideas for developing a glucose responsive insulin (GRI) drug. The Agnes Varis GRI Grand Challenge Prize, the first stage of which was called the “Theoretical...

During the holidays , you eat and drink with everyone from your second cousin’s hair stylist to the soccer coach for your college roommate’s kid. If you have T1D, as I do, be ready for well-meaning people to ask you some of the same questions...

One of the toughest challenges in halting or reversing the autoimmune process that destroys beta cells and causes type 1 diabetes is doing so in a way that does not compromise a person’s entire immune system. Antigen-specific immune therapy research...

Help me tell Congress, “Renew the Special Diabetes Program (SDP)” by sending a quick email (…and thanks again to those of you that made calls earlier this month, use this email alert to follow up )! As you know, the SDP is a critical...

Good morning. As I have spent the last days preparing for the visit of my family for the Thanksgiving holiday, I have been thinking about what I am grateful for. As the National Chair of JDRF Advocacy and the parent of a daughter with type 1 diabetes...

After all of the work many of you put into making the artificial pancreas guidance from FDA a reality, I wanted to say thank you and congratulations! FDA released the final guidance and included nearly all of JDRF’s suggested changes – see...

In September, Living Cell Technologies (LCT) revealed positive results from its JDRF-funded Phase II study of DIABECELL—a unique proprietary encapsulation technology comprised of encapsulated pancreatic islets from pigs. According to LCT’s...

It’s a critical time for type 1 diabetes (T1D) research, and we need you to call your members of Congress today (or tomorrow, 11/15) and tell them “don’t stop now, renew the SDP!” The Special Diabetes Program (SDP) provides $150...

November is National Diabetes Month. We also celebrate Veterans’ Day and honor those who have served or are serving in the United States military. Captain Joseph Budzyn of Mokena, Illinois, an Eagle Scout and a 2008 graduate of the Air Force Academy...

For the past few months, we’ve been stressing the importance of the Special Diabetes Program (SDP) , which has in one way or another changed the lives of every person living with diabetes today. Since Congress and the Administration created the...

In today's Wall Street Journal, you'll find an Op-Ed entitled "The Folly of Defunding Diabetes Research," authored by JDRF International Chairman and owner of the NFL's New York Jets, Robert Wood "Woody" Johnson, IV. If...

We’re less than 2 weeks out from the last day to apply to the JDRF Children's Congress 2013 - Thursday, November 1 or T1D Day! If you know someone age 4 to 17 with T1D (type 1 diabetes) and has never been a CC Delegate, I hope you’ll encourage...

The Children’s Congress 2013 (CC13) applications are due on November 1, 2012, the event will be held in Washington, D.C. from July 8-10, 2013 so don't miss your chance to participate! I also wanted to share another quick note from Angie Platt...

Eye disease is one of the most common complications of type 1 diabetes. Eye disease in people with diabetes, also known as diabetic retinopathy , is caused by chronic high blood sugar levels, which can damage the blood vessels in the retina of the eye...